Watch List for Investors: China Pharma Holdings (NYSEMKT:CPHI), Owens & Minor (NYSE:OMI), The Buckle (NYSE:BKE), Aldeyra Therapeutics (NASDAQ:ALDX)

SolarCity Corporation (NASDAQ:SCTY) shares moved down -0.49% in last trading session and ended the day at $47.11. SCTY Gross Margin is 35.30% and its has a return on assets of -0.60%. SolarCity Corporation (NASDAQ:SCTY) quarterly performance is -11.11%.

On 6 October, SolarCity Corporation (NASDAQ:SCTY) and Temecula Valley Unified School District (TVUSD) are together installing a six megawatt solar and energy storage project across 19 schools and the district’s administrative office. The project, which includes energy storage systems at five sites, required no upfront investment and is expected to save the district more than $520,000 within the first year of operation alone, and $35 million over 25 years by providing affordable power at a discount to utility rates.

China Pharma Holdings, Inc. (NYSEMKT:CPHI) ended the last trading day at $0.18. Company weekly volatility is calculated as 16.69% and price to cash ratio as 1.71. China Pharma Holdings, Inc. (NYSEMKT:CPHI) showed a weekly performance of -2.17%.

On 08 October, Owens & Minor Inc. (NYSE:OMI) shares moved down -0.26% and was closed at $34.34. OMI EPS growth in last 5 year was -10.60%. Owens & Minor Inc. (NYSE:OMI) year to date (YTD) performance is 0.04%.

Zacks lowered shares of Owens & Minor (NYSE:OMI) from a hold rating to a sell rating in a research report sent to investors on Monday morning, AnalystRatingsNetwork.com reports.

The Buckle, Inc. (NYSE:BKE) shares moved down -5.75% in last trading session and ended the day at $36.08. BKE Gross Margin is 43.70% and its has a return on assets of 27.80%. The Buckle, Inc. (NYSE:BKE) quarterly performance is -21.63%.

The Buckle, Inc. (NYSE:BKE) announced that at its quarterly meeting of the Board of Directors, held on September 14, 2015, the Board authorized a $0.23 per share quarterly dividend to be paid to shareholders of record at the close of business on October 15, 2015, with a payment date of October 27, 2015.

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) caters to the Healthcare space. Its weekly performance is -8.45%. On the last day of trading company shares ended up at $5.15. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) distance from 50-day simple moving average (SMA50) is -28.25%.

On 29 September, Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) announced that it has enrolled the first patient in a Phase IIa clinical trial of NS2 for the treatment of allergic conjunctivitis.